HiRO - Harvest Integrated Research Organization’s Post

Two weeks to go! I'm very excited to network, learn more about recent trends, and spread the word about the benefits of conducting clinical trials in Eastern and Central Europe. Please feel free to reach out to me if you would like to meet at the event. Let's make the best of this opportunity! #BioAsia2024 #OCTClinical #ClinicalTrialStrategy #DrugDevelopment #OCTteam #ClinicalTrials #ClinicalResearch

Celebrating another successful event in Japan with the 4G Clinical Team and our esteemed partners. Our Tokyo Symposium was a dynamic forum where we delved into emerging trends and shared best practices shaping the future of the clinical trial industry. A sincere thank you to Buz Hillman, Mihoko Yamanaka, Hiroaki Yasui, Jon Lee, Junko Ohta, Takuya Kitami, Elizabeth Rickenbacher, PhD, Naoharu Yamamoto, Martijn Princen, and all the dedicated individuals who contributed to the success of this event. Here’s to ongoing teamwork and creativity in furthering clinical research. #TokyoSymposium #ClinicalTrials #TeamWork #RTSM #clinicaltrials #pharma #JapanSymposium #IndustryLeadership #4gclinical

Deep dive into AMED's Role in Japan's Drug Discovery Future Although SIIFIC is not a registered VC, SIIFIC co-invests with registered VCs, enhancing the support network for startups and aligning with AMED's mission to advance medical innovation. Let's deep dive into AMED's Role in Japan's Drug Discovery Future! 🚀 Welcome to an Exploration of AMED's Increasing Role on Japan's Drug Discovery Landscape 🚀 The field of drug discovery is undergoing a transformation, driven by advancements in technology, collaborative research, and innovative funding mechanisms. At the heart of this transformation in Japan is the Japan Agency for Medical Research and Development (AMED). Established in April 2015, AMED plays a critical role in advancing scientific discoveries and translating them into viable therapies that can save lives and improve public health. AMED's Strengthening Program for Pharmaceutical Startup Ecosystem/Venture Capital supports pharmaceutical startups and venture capital firms, providing financial support, resources, and expert guidance to help startups navigate the complexities of drug development. 🌐 Public-Private Partnerships 🌐 AMED promotes collaboration between academia, industry, and government to ensure that innovative solutions can be rapidly translated into practical applications. This approach accelerates the pace of discovery and enhances the overall quality and impact of research. Stay tuned for our 10-part series, where we will delve into AMED's Strengthening Program for Pharmaceutical Startup Ecosystem/Venture Capital. Each post will explore different aspects of the programme, from the criteria for registered VCs to the success stories of pharmaceutical startups. Join us as we uncover how AMED is shaping the future of drug discovery in Japan. #AMED #PharmaceuticalStartups #VentureCapital #DrugDiscovery #HealthcareInnovation #MedicalResearch #JapanInnovation #PublicPrivatePartnerships #SIIFIC #SIIFICWellnessFund https://lnkd.in/ghDQCvhJ

“While supporting the operation of clinical trials is one objective, I think the true mission of a CRO is also to support the identification of new promising drugs and be a strong partner for bio-venture businesses. We want to support continued innovation to bring more effective and affordable solutions to patients and empower them to optimize their healthcare journeys.” - Kazuo Nakamura, CEO and founder, CMIC Group In the recent executive interview with Endpoints News, our CEO and COO answer questions ranging from the journey of CMIC’s beginnings to the future state of the company and the industry as a whole. Read this informative article to get the full picture of Japan’s first CRO: https://lnkd.in/dtceRVxb

🌟 What's New in Drug Discovery? Let's Dive In! 🌟 Hello, fellow drug discovery aficionados! The world of drug discovery is always buzzing with new challenges and innovations. Let’s talk about what’s currently shaping our industry. 🔬 Key Needs in Drug Discovery: - Cutting-Edge Technology: What new tools are revolutionizing your lab work? - Collaboration: How do we build stronger partnerships for faster breakthroughs? - Regulatory Hurdles: What’s the best way to navigate the ever-changing landscape? 💡 Emerging Trends: - AI and Big Data: How are these tools enhancing our research capabilities? - Personalized Medicine: What strides are we making in tailoring treatments? - Sustainability: How are we making our processes greener? 💬 Your Thoughts? I’d love to hear from you! What’s the biggest challenge you’re facing in drug discovery today? What innovations are you most excited about? Drop a comment or send me a message—let’s get a conversation going! 🚀 Let's Connect! By the way, if you're as passionate about these topics as I am, we’ve got an incredible opportunity to dive deeper. The 17th DDSS Summit in Munich on October 23-24 will be a fantastic place to meet, learn, and share ideas. Feel free to message me for more details! 🔗 https://lnkd.in/dSmySJWC #DrugDiscovery #Pharma #HealthcareInnovation #AIinHealthcare #PrecisionMedicine #Sustainability #Networking #DDSSSummit

Join ERGOMED Group TODAY at Outsourcing in Clinical Trials Europe 2024! 💡 Discover how Ergomed solutions can optimize your operations at Booth #80. Our Clinical Research experts, Marijana Prodan and Alba Peña Paris, along with PrimeVigilance 's Iwona Kmicikiewicz, joined by our commercial team of Bernd Saynisch and Aleksandra Marinkovic, are available to answer any queries you may have. Looking forward to continuing discussions today! #ClinicalResearch #OCTEurope2024 #Barcelona

#PharmaSynergy, set for February 8-9, 2024, in London, is gaining momentum! Every day, we welcome new #BD & #Licensing professionals representing the growth pharma from around the world! Maximize your time at the #B2Bpartnering by meeting the right people! We pre-select #mutually_compatible companies based on their #product_portfolio. In February, you will have the opportunity to meet companies focused on: -      #Rx #Generics & Value-Added Medicines (#VAMs) -      #Biosimilars, #Specialty, & #Hospital_Products -      NEW! #Orphan drugs & #NCEs (late phase) Flexible & Efficient partnering platform. Our filtering system allows you to find partners based on the therapeutical indication, partnering framework, product type, and geography of interest, among other practical filters.   Connect with regional pharma players from #mature & #growth regions. Our multinational team reaches out to growth BD&L pharma executives in #Europe, #MENA, #LATAM, and #APAC. See for yourself & join us in London: https://lnkd.in/ez9VnXj8

Great Day 01 A lot of update about drug supply efficiency, medical perspective approach about cell therapy, biotech per directives about how to choose partners and CROs Looking forward to meet again and more great people at the conference Visit HiRO booth #bioeurope #bioboston #bioasia #biotech #drugsupply #logistics #efficiency #researchanddevelopment #biotechinnovation #clinicaldevelopment #investing #korea #konectkorea

🌍✈️ Exciting news on the horizon! We are eager to share that we will participate in events across Europe and the USA in 2024. 🚀 Mark your calendars for these key gatherings in the Pharma & Life Sciences as well as Clinical Trials realms, where we will be at the forefront of innovation and collaboration. 🔍 Stay tuned for exclusive insights and opportunities as we embark on this dynamic adventure. Let us connect with you at one of the events! #PharmaLifeSciences #ClinicalTrials #InnovationJourney

Dear Connections 😃, Is there an increase in awareness of reading the labels beyond the lines? 🤔 Why is it important to have your own scientifically backed health claims? 😮 Are these questions buzzing around you? 🤷♂️ Let us discuss more at Food ingredients Europe at your booth 💬. Let's make an impact together for your unique product.🤝 #Clinicaltrials #foryou #forgrowth